Organon & Co (OGN)

Exchange
NYSE
Symbol
OGN
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    14.54
  • High
    14.92
  • Low
    14.41
  • Close
    14.58
  • Volume
    31,638,800

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.49
Receivables turnover
3.59
Payables turnover
3.49
Working capital turnover
3.94
Days of inventory on hand (DOH)
104.66
Days of sales outstanding (DSO)
101.64
Number of days of payables
104.58
Fixed asset turnover
5.29
Total asset turnover
0.52
 Liquidity ratios
Current ratio
1.54
Quick ratio
0.84
Cash ratio
0.24
Cash conversion cycle
101.72
 Solvency ratios
Debt-to-assets ratio
0.73
Debt-to-capital ratio
1.01
Debt-to-equity ratio
—
Financial leverage ratio
—
Interest coverage
2.28
 Profitability ratios
Gross profit margin
26.78%
Operating profit margin
-14.85%
Pretax margin
10.75%
Net profit margin
16.33%
Operating return on assets (Operating ROA)
-7.71%
Return on assets (ROA)
8.48%
Return on total capital
13.82%
Return on equity (ROE)
—